Insider Trading History of O'day Daniel Patrick

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of O'day Daniel Patrick since 2020. This trader's CIK number is 1638643. At the time of last reporting, O'day Daniel Patrick was the Chairman & CEO of Gilead Sciences, Inc.. (stock ticker symbol GILD). Also see all insider trading activities at Gilead Sciences, Inc..


Yearly summary of insider trading at Gilead Sciences, Inc. (GILD) by O'day Daniel Patrick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 GILD 0 $0 40,000 $4,485,740 34,449 $0
2024 GILD 0 $0 0 $0 60,825 $0
2023 GILD 0 $0 0 $0 56,345 $0
2022 GILD 0 $0 0 $0 88,188 $0
2021 GILD 0 $0 0 $0 65,086 $0
2020 GILD 0 $0 0 $0 54,288 $0


Insider trading of Gilead Sciences, Inc. (GILD) by O'day Daniel Patrick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-28 GILD Sale 10,000 113.63 1,136,300
2025-07-28 GILD Sale 10,000 113.63 1,136,290
2025-06-30 GILD Sale 10,000 110.78 1,107,750
2025-06-10 GILD Option Ex 10,425 .00 0
2025-05-30 GILD Sale 10,000 110.54 1,105,400
2025-03-10 GILD Option Ex 24,024 .00 0
2024-12-10 GILD Option Ex 10,295 .00 0
2024-09-10 GILD Option Ex 10,295 .00 0
2024-06-10 GILD Option Ex 10,295 .00 0
2024-03-10 GILD Option Ex 29,940 .00 0
2023-12-10 GILD Option Ex 7,347 .00 0
2023-09-10 GILD Option Ex 7,348 .00 0
2023-03-10 GILD Option Ex 30,288 .00 0
2023-03-01 GILD Option Ex 11,362 .00 0
2022-12-10 GILD Option Ex 3,300 .00 0
2022-09-10 GILD Option Ex 3,301 .00 0
2022-06-10 GILD Option Ex 3,300 .00 0
2022-03-10 GILD Option Ex 24,003 .00 0
2022-03-01 GILD Option Ex 54,284 .00 0
2021-03-10 GILD Option Ex 10,800 .00 0
2021-03-01 GILD Option Ex 54,286 .00 0
2020-03-01 GILD Option Ex 54,288 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'day Daniel Patrick (Chairman & CEO of Gilead Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.